Home / Inspections / 1211521

FDA Inspection 1211521 — Pentagon Blood Collection Site

Pentagon Blood Collection Site — FEI 3010596305

The FDA completed an inspection of Pentagon Blood Collection Site on July 18, 2023 in Washington, DC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 18, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Washington, DC (United States)

Facility

Other inspections at this facility

  • 1281608 (NAI Wed Sep 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1100722 (VAI Thu Aug 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1022639 (NAI Fri Jul 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 936889 (NAI Wed Jul 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 893225 (NAI Fri Aug 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources